|
ZKSCAN4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.578000E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.956400E-04 |
| Normal-vs-Stage2 |
1.082400E-02 |
| Normal-vs-Stage3 |
4.247600E-04 |
| Normal-vs-Stage4 |
4.803200E-04 |
| Stage1-vs-Stage2 |
5.137400E-01 |
| Stage1-vs-Stage3 |
6.641200E-01 |
| Stage1-vs-Stage4 |
5.681600E-01 |
| Stage2-vs-Stage3 |
3.767400E-01 |
| Stage2-vs-Stage4 |
3.190200E-01 |
| Stage3-vs-Stage4 |
8.257200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.352700E-04 |
| Normal-vs-AfricanAmerican |
9.644400E-03 |
| Normal-vs-Asian |
7.050100E-02 |
| Caucasian-vs-AfricanAmerican |
7.676000E-01 |
| Caucasian-vs-Asian |
3.367700E-02 |
| AfricanAmerican-vs-Asian |
2.595000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.524300E-03 |
| Normal-vs-Female |
1.807180E-04 |
| Male-vs-Female |
1.009360E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.833910E-04 |
| Normal-vs-Age(41-60Yrs) |
1.504580E-03 |
| Normal-vs-Age(61-80Yrs) |
1.058740E-03 |
| Normal-vs-Age(81-100Yrs) |
1.388370E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.341400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.898800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.130600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.247400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.861200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.850800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.426800E-01 |
| Classical-VS-Follicular |
3.691800E-02 |
| Classical-VS-Other |
8.607800E-01 |
| Classical-VS-Normal |
1.938480E-03 |
| Tall-VS-Follicular |
5.943200E-01 |
| Tall-VS-Other |
8.359800E-01 |
| Tall-VS-Normal |
2.064400E-03 |
| Follicular-VS-Other |
6.276000E-01 |
| Follicular-VS-Normal |
1.013150E-04 |
| Other-VS-Normal |
1.767190E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.438630E-03 |
| Normal-vs-N1 |
2.39850000000041E-05 |
| N0-vs-N1 |
3.829700E-02 |
|
|
